- Home
- RVPH vs FBIO Comparison
RVPH vs FBIO Comparison
Compare RVPH & FBIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RVPH
- FBIO
- Stock Information
- Founded
- RVPH 2006
- FBIO 2006
- Country
- RVPH United States
- FBIO United States
- Employees
- RVPH N/A
- FBIO N/A
- Industry
- RVPH Biotechnology: Pharmaceutical Preparations
- FBIO Biotechnology: Pharmaceutical Preparations
- Sector
- RVPH Health Care
- FBIO Health Care
- Exchange
- RVPH Nasdaq
- FBIO Nasdaq
- Market Cap
- RVPH 32.8M
- FBIO 49.1M
- IPO Year
- RVPH N/A
- FBIO N/A
- Fundamental
- Price
- RVPH $0.34
- FBIO $1.86
- Analyst Decision
- RVPH Strong Buy
- FBIO Strong Buy
- Analyst Count
- RVPH 5
- FBIO 2
- Target Price
- RVPH $9.00
- FBIO $21.00
- AVG Volume (30 Days)
- RVPH 2.4M
- FBIO 227.1K
- Earning Date
- RVPH 08-13-2025
- FBIO 08-12-2025
- Dividend Yield
- RVPH N/A
- FBIO N/A
- EPS Growth
- RVPH N/A
- FBIO N/A
- EPS
- RVPH N/A
- FBIO N/A
- Revenue
- RVPH N/A
- FBIO $57,784,000.00
- Revenue This Year
- RVPH N/A
- FBIO $51.59
- Revenue Next Year
- RVPH N/A
- FBIO $44.74
- P/E Ratio
- RVPH N/A
- FBIO N/A
- Revenue Growth
- RVPH N/A
- FBIO N/A
- 52 Week Low
- RVPH $0.30
- FBIO $1.33
- 52 Week High
- RVPH $4.28
- FBIO $2.89
- Technical
- Relative Strength Index (RSI)
- RVPH 27.45
- FBIO 51.97
- Support Level
- RVPH $0.72
- FBIO $1.70
- Resistance Level
- RVPH $0.83
- FBIO $2.15
- Average True Range (ATR)
- RVPH 0.07
- FBIO 0.10
- MACD
- RVPH -0.03
- FBIO -0.01
- Stochastic Oscillator
- RVPH 9.67
- FBIO 35.56
About RVPH Reviva Pharmaceuticals Holdings Inc.
Reviva Pharmaceuticals Holdings Inc is a late-stage pharmaceutical company that discovers, develops, and seeks to commercialize therapeutics for diseases. The current pipeline of the company focuses on the central nervous system, inflammatory, and cardiometabolic diseases. The company uses a chemical genomics-driven technology platform and proprietary chemistry to develop new medicines. The company's pipeline currently has two drug candidates, Brilaroxazine (RP5063) which is intended to treat multiple neuropsychiatric indications, including schizophrenia, bipolar disorder, depressive disorder, attention-deficit/hyperactivity disorder, behavioral and psychotic symptoms of dementia or Alzheimer's disease and Parkinson's disease psychosis and its other drug candidate is RP1208.
About FBIO Fortress Biotech Inc.
Fortress Biotech Inc is a biopharmaceutical company. The firm is involved in the business of acquiring, developing, and commercializing pharmaceutical and biotechnology products. Its product portfolio encompasses Qbrexza, Accutane, Amzeeq, Zilxi, Targadox, Ximino, and Exelderm. The business activities of the group are functioned through Dermatology Product Sales, and Pharmaceutical and Biotechnology Product Development. It derives the majority of its revenues from Dermatology segment. Its subsidiaries also operate in biotechnology, pharmaceutical, oncology and therapeutics sectors.